US drug regulator issues guidance to tackle delays speed-up generic approvals

US drug regulator issues guidance to tackle delays speed-up generic approvals In the latest draft guidance, USFDA tried to tackle a major loophole called #39;citizen petitions#39; used by branded drug makers or innovators to delay the entry of generic drugs

No comments:

Post a Comment